Diagnostic Imaging Tools to Advance Pharmaceutical Drug Development

Jan 27th, 2005Feb 1st, 2005
Washington, DC
US
A three-day conference that includes presentations on ROI of imaging, what imaging can actually do, and drug development from inception to failure, addressing regulatory and technological issues. Also includes integrating PET into medicinal chemistry.
Latest in Home
Ai Hand
LLMs rapidly evolving in nuclear medicine
October 24, 2025
2025 10 24 Jmri Said Fig2 Thumbnail
DWI with fat correction identifies liver scarring in MASLD patients
October 24, 2025
Join Us!
Sponsored
Join Us!
October 22, 2025
Prostate Imaging
PSMA-PET may require selective use to be cost-effective
October 24, 2025
More in Home
LLMs rapidly evolving in nuclear medicine
By Will Morton
Large language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.
October 24, 2025
Ai Hand
DWI with fat correction identifies liver scarring in MASLD patients
By Kate Madden Yee
An MRI technique that corrects for fat in the liver appears to perform comparably to MRE for detecting fibrosis.
October 24, 2025
2025 10 24 Jmri Said Fig2 Thumbnail
Ghost scans problematic in POCUS trauma exams
By Amerigo Allegretto
Rates of ghost scans -- where POCUS images are not saved -- vary by imaging facility, but are high overall in emergency settings.
October 24, 2025
Emergency Sign
PSMA-PET may require selective use to be cost-effective
By Will Morton
Yale University researcher developed a decision-analytic model to estimate lifetime cost outcomes associated with PSMA-PET.
October 24, 2025
Prostate Imaging
New procedure treats chronic pain in toe joints
By Will Morton
Median pain scores dropped for 27 patients from nine to one after five months.
October 23, 2025
Toe Joint
HPI study, online tool identify and predict cancer disparities
By Kate Madden Yee
Factors such as poverty and environmental toxins are some of the most common community-level predictors of U.S. cancer disparities.
October 23, 2025
Health Disparities Label Adobe Eco Lens
Radiology CSI: CT helps medical examiners determine cause of death
By Kate Madden Yee
Kalpana Kanal, PhD, of the University of Washington Medical Center in Seattle, spoke to AuntMinnie about forensic CT.
October 23, 2025
This image depicts comminuted skull fractures sustained in a pedestrian motor vehicle accident. These are difficult to document by a standard autopsy because the individual fragments are displaced during the internal examination and dissection of the head.
Radiomics plus DL improve prediction of lung cancer invasiveness
By Kate Madden Yee
This combined model could support better treatment planning for patients with early-stage disease.
October 22, 2025
Lung Cancer
False-negative breast exams on the rise
By Amerigo Allegretto
False-negative screening exams are rising among women, influenced by patient- and facility-level factors.
October 22, 2025
Mammo Reading 400
Is it time to put global health in radiology education curricula?
By Amerigo Allegretto
A lack of faculty expertise and less time in education curricula may hinder radiologist participation in global health efforts.
October 22, 2025
Globe Digital Screens
What’s the best treatment for 'eloquent' brain AVMs?
By Will Morton
Researchers performed the first direct comparisons of two emerging techniques for treating arteriovenous malformations (AVMs).
October 21, 2025
Brain Avms Thumbnail
Preop MRI lessens younger women's risk of breast cancer recurrence
By Amerigo Allegretto
Preoperative MRI may lead to lower risk of ipsilateral in-breast recurrence in younger women with newly diagnosed breast cancer.
October 21, 2025
Images in a 49-year-old patient originally treated for hormone receptor-positive invasive cancer without preoperative MRI who developed bloody nipple discharge two years after surgery. (A) Left mediolateral oblique mammogram shows new grouped pleomorphic calcification (arrow) adjacent to the previous operation site. (B) Transverse ultrasound image shows a 2.3-cm hypoechoic mass (arrows) with calcifications. (C) Axial contrast-enhanced fat-saturated T1-weighted MRI scan shows an irregular, heterogeneously enhancing mass (arrow) in the left breast, adjacent to the operation site. The final pathologic examination confirmed recurrent invasive ductal carcinoma.
Page 1 of 179
Next Page